Optimizing Combination Therapy for Acute Lymphoblastic Leukemia Using a Phenotypic Personalized Medicine Digital Health Platform: Retrospective Optimization Individualizes Patient Regimens to Maximize Efficacy and Safety. [electronic resource]
Producer: 20181120Description: 276-288 p. digitalISSN:- 2472-6311
- Antineoplastic Agents -- administration & dosage
- Drug Therapy -- methods
- Drug Therapy, Combination -- adverse effects
- Drug-Related Side Effects and Adverse Reactions -- pathology
- Humans
- Precision Medicine -- adverse effects
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.